Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only 
U.S. Dollar Slides for Third Straight Week as Rate Cut Expectations Boost Euro and Pound 
Oil Prices Edge Higher as U.S. Seizes Sanctioned Venezuelan Tanker 
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns 
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Gold Prices Dip as Markets Absorb Dovish Fed Outlook; Silver Eases After Record High 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans 
Russia Stocks End Flat as Energy and Retail Shares Show Mixed Performance 
Asian Stocks Rally as Tech Rebounds, China Lags on Nvidia Competition Concerns 
Olympus had agreed to sell its microscope unit to private equity firm Bain Capital for $3.1 billion as it speeds up the overhaul of its business portfolio to focus solely on medical technology
The microscope unit, which also manufactures industrial endoscopes and x-ray analyzers, will be transferred to Bain on January 4, subject to antitrust regulatory approvals in Japan and elsewhere.
Olympus stated that the transfer to Bain would benefit the company by allowing it to grow through more agile and flexible decision-making based on market needs.
Bain edged global private equity firms such as Carlyle Group and KKR & Co. for the right to acquire the microscope unit.
Olympus said the transfer to Bain would be in its best interest to allow the business to grow with more agile and flexible decision-making based on market needs.
Bain won over global private equity firms such as Carlyle Group and KKR & Co.
Bain owns flash memory chip maker Kioxia Holdings and is proceeding to a second bidding round for Toshiba.
